Lipocine (LPCN) Misses Q3 EPS by 67c
Tweet
Share
E-mailGet Alerts LPCN Hot Sheet
Join SI Premium – FREE
Lipocine (NASDAQ: LPCN) reported Q3 EPS of ($1.27), $0.67 worse than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Lipocine (LPCN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Jefferies Reinstates Talen Energy (TLN) at Hold
- Stifel Starts Victrex Plc. (VCT:LN) (VTXPF) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
